Experimental characterization reveals persistent blue luminescence in gallium phosphate phosphor-in-glass composites, indicating potential for emergency signaling and solar cell sensitization.
Phosphor-in-glass (PiG) is a composite material that can combine the chemical stability and more versatile molding and processing of glasses and the singular properties of luminescent polycrystalline materials . Persistent luminescent phosphors have been raising attention due to their long emission times without the need for a steady irradiation source. The association of these polycrystalline materials with transparent glassy hosts leads to the obtainment of robust luminescent bulk materials and expands the possibilities of commercial applications. In this work, the Sr 2 MgSi 2 O 7 :Eu 2+ ,Dy 3+ (SMSO) persistent luminescent material was incorporated into a new gallium phosphate glass system with composition 80NaPO 3 – 20Ga 2 O (NaPGa), through the conventional melt-quenching technique and fully characterized from the structural and spectroscopic viewpoints. The composites were prepared using 2, 5, 10, and 20 wt% of SMSO at 900 or 950 °C. It was observed that the higher melting temperature induces the oxidation of Eu 2+ ions, which can reduce the persistent luminescent emission. High SMSO concentrations increase the glass melt viscosity, hampering the molding step but optimized samples were successfully obtained as transparent bulk materials with efficient emission in the blue spectral region and promising applications in emergency signaling and as solar cell sensitizers. • New PersL PiG composites combine NaPO 3 – Ga 2 O 3 glass stability with luminescent properties of Sr 2 MgSi 2 O 7 :Eu 2+ ,Dy 3+ material. • The match between the glass transmittance and the SMSO absorption allows applications using sunlight excitation. • The lower melting temperature prevents the oxidation of Eu 2+ ions, enhancing the PersL emission. • The NaPGaO glass stability allows for more durable applications under exposure to sunlight and weathering conditions.
No takes yet. Share an insight, caveat, or question.
Merízio et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: